# FOLFOX6 Totally Neoadjuvant Chemoradiation Therapy in Locally Advanced Rectal Cancer: A Real World Study

> **NCT02887313** · PHASE2 · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 200 (estimated)

## Conditions studied

- Rectal Cancer

## Interventions

- **DRUG:** mFOLFOX6
- **RADIATION:** Radiotherapy

## Key facts

- **NCT ID:** NCT02887313
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-07
- **Primary completion:** 2019-05
- **Final completion:** 2020-08
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2020-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02887313

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02887313, "FOLFOX6 Totally Neoadjuvant Chemoradiation Therapy in Locally Advanced Rectal Cancer: A Real World Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02887313. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*